← Leaderboards
Lilyana Amezcua
Ut Southwestern Medical Center
$1,085,117
Attributed
$3,067,691
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $905.7K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,067,691 · 2
By mechanism
R01$2,692,372 · 1
RF1$375,319 · 1
Top collaborators
- Nancy L Monson5 shared
- Timothy Vartanian5 shared
- Jacob L Mccauley1 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Kevin Kyung Park$6,854,716
- Amit Singal$17,388,983
- Amy E Hughes$1,276,835
- Rasmi Girijavallabhan Nair$225,500
- Salma Kaochar$2,491,907
Others in their field
Other Emerging Leaders on “Prevalence”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$33,290,196
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Phd, Stephen Schwartz · Fred Hutchinson Cancer Research Center$26,641,749
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Scarlett Lin-Gomez · University Of California, San Francisco$23,974,147
Research focus
PrevalenceMediatingSeverity Of IllnessDisabilityMultiple Sclerosis PatientImmuneMultiple SclerosisReportingCaringGeneticFutureDisease ProgressionFaceAntibodiesFlow CytometryCellsEventGenesCognitive DisabilityAtrophicCohortGray MatterB-LymphocytesBiological
Grant awards (6)
Immunology of advancing disease among minorities with Multiple Sclerosis$530,415
R01 · FY2025 · NS
Capacity building for timely diagnosis of Multiple Sclerosis and prevention of disability$375,319
RF1 · FY2025 · TW · contact PI
Immunology of advancing disease among minorities with Multiple Sclerosis$519,124
R01 · FY2024 · NS
Immunology of advancing disease among minorities with Multiple Sclerosis$536,540
R01 · FY2023 · NS
Immunology of advancing disease among minorities with Multiple Sclerosis$537,221
R01 · FY2022 · NS
Immunology of advancing disease among minorities with Multiple Sclerosis$569,072
R01 · FY2021 · NS